Introduction {#section5-1474515119850011}
============

Heart failure (HF) is an unpredictable life-limiting condition that is challenging to self-manage. People with HF typically experience poor levels of health-related quality of life (HRQoL) due to episodes of breathlessness, oedema, fatigue and associated anxiety and depression.^[@bibr1-1474515119850011]^ Families and social networks frequently support people living with long-term conditions, including HF.^[@bibr2-1474515119850011],[@bibr3-1474515119850011]^ Caregivers for people with HF have identified three distinct needs: (1) supporting HF management, including coping with the variability of HF symptoms, understanding and managing medicines, providing emotional support, promoting exercise and physical activity; (2) developing the caregiver role, including communicating with health professionals, managing their own well-being; and (3) developing skills to engage social support, and voluntary and services while recognizing that the long-term future may uncertain.^[@bibr4-1474515119850011],[@bibr5-1474515119850011]^ However, there is currently a paucity of evidence on interventions that support caregivers of people with HF in their role.^[@bibr6-1474515119850011][@bibr7-1474515119850011][@bibr8-1474515119850011]--[@bibr9-1474515119850011]^

Home-based programmes can widen access to cardiac rehabilitation (CR) and have been shown to be as effective as centre-based models for people after myocardial infarction and coronary revascularisation.^[@bibr10-1474515119850011],[@bibr11-1474515119850011]^ Moreover, home-based programmes also have greater potential to involve the caregivers in the rehabilitation process and offer them support. Rehabilitation EnAblement in Chronic Heart Failure (REACH-HF) is a de novo rehabilitation self-management programme for patients with HF and their caregivers. The REACH-HF intervention is novel in a number of ways: (1) theory-based; (2) co-developed with stakeholders (patients, caregivers, clinicians, service providers); (3) based on intervention mapping; (4) delivered in home-based setting (in contrast to the traditional hospital/centre-based venue) by trained health-professionals; and (5) and directed at both patients with HF and their caregivers.^[@bibr12-1474515119850011][@bibr13-1474515119850011]--[@bibr14-1474515119850011]^

A multicentre randomized controlled trial has shown that, compared to usual care alone, the addition of the REACH-HF intervention improves the disease-specific HRQoL of people with HF with reduced ejection fraction (HFrEF) and is a cost-effective use of healthcare resources.^[@bibr15-1474515119850011],[@bibr16-1474515119850011]^ The aims of this paper are twofold: first, to compare the caregiver outcomes between the REACH-HF and control groups; second, to report the views and perceptions of caregivers on their experience of using the REACH-HF intervention.

Methods {#section6-1474515119850011}
=======

Study design {#section7-1474515119850011}
------------

The published protocol provides a full description of the trial design and procedures.^[@bibr12-1474515119850011]^ In summary, men and women aged ⩾18 years with a confirmed diagnosis of HFrEF on echocardiography or angiography (i.e. left ventricular ejection fraction \<45% within the preceding five years) were recruited from primary and secondary care settings in four centres in the United Kingdom (Birmingham, Cornwall, Gwent and York). At study entry, patients were asked to nominate if they had a caregiver, i.e. a spouse, other relative or friend, who provides unpaid support to patients. Unpaid support includes emotional support, prompting with taking medications, observing for signs and symptoms of HF, getting prescriptions, encouraging participation in social events and physical activity, helping with household tasks or providing physical care.

Patients were randomly allocated in a 1:1 ratio, stratified by investigator site and baseline plasma N-terminal proB-type natriuretic peptide levels (⩽2000 vs \>2000 pg/ml), using minimization to facilitate balance between the groups. Randomization numbers were computer generated and assigned in strict sequence at the point of randomization. To maintain concealment, the Peninsula Clinical Trials Unit used a password-protected, Web-based randomization system to allocate participants after consent was obtained and baseline assessment data entered. Caregivers were allocated to receive the REACH-HF intervention (REACH-HF group) or not (control group) in accord with the random allocation of their patient partner.

The investigation conformed to the principles outlined in the Declaration of Helsinki and was approved by the North West Lancaster Research Ethics Committee (14/NW/1351). Written informed consent was obtained from both patient and caregiver participants.

REACH-HF intervention {#section8-1474515119850011}
---------------------

A detailed description of the REACH-HF intervention, its development including extensive consultation and involvement of our patient and public involvement group and its theoretical underpinnings is published elsewhere.^[@bibr14-1474515119850011]^

The REACH-HF intervention is a comprehensive, evidence-informed, patient-centred, theory-based, self-care support programme that includes four core elements:^[@bibr12-1474515119850011],[@bibr14-1474515119850011],[@bibr15-1474515119850011]^

-   'REACH-HF manual' -- providing information on: (1) understanding HF, (2) managing HF in terms of including change of lifestyle key self-care targets (building physical fitness through exercise, managing fluids, managing medications and managing stress/anxiety/low mood) and (3) living with the uncertainty of HF.

-   'Progress tracker' -- allows patients to record symptoms, physical activity and other actions related to self-care; this was designed to act as a 'scaffold' to aid reflection on progress, increase their understanding of how self-care actions affect their physical and mental wellbeing, and adapt their self-care strategies over time.

-   'Family and friends resource' -- for use by caregivers, including advice on providing support, becoming a caregiver, managing the caregiver's own health and wellbeing and getting help.

-   Facilitation by cardiac nurses or physiotherapists, including assessment of individual patient and caregiver needs and concerns and tailoring of the intervention content to address these; this element was supported by a three-day training course for facilitators on how to deliver the intervention using a patient-centred style of communication.

The intervention was delivered at the patient's home via a mixture of face-to-face and telephone contacts over 12 weeks (typically 4--6 contacts). During home visits and telephone follow-up, facilitators supported the participants and caregivers to understand and manage HF, set goals and develop self-care strategies.^[@bibr15-1474515119850011]^ Facilitators were asked to spend time with the caregivers to help them understand how best to support the patient, as well as to look after their own wellbeing.

Outcomes and interviews {#section9-1474515119850011}
-----------------------

Caregiver outcomes included the Hospital Anxiety and Depression scale (HADS),^[@bibr17-1474515119850011]^ generic HRQoL (EQ-5D-5L questionnaire),^[@bibr18-1474515119850011]^ Family Caregiver Quality of Life (FamQol),^[@bibr19-1474515119850011]^ Caregiver Burden Questionnaire for Heart Failure (CBQ-HF),^[@bibr20-1474515119850011]^ and Caregiver's Contribution to Self-care of HF Index (CC-SCHFI).^[@bibr21-1474515119850011]^ Outcome data were collected during three clinic visits at baseline, four and 12 months, and by postal questionnaire at six months. At the baseline clinic visit, sociodemographic data was also collected. Data was collected by research nurses who were blinded to group allocation.

Twenty caregivers in the REACH-HF group were selected for interview at 4 and 12 months using maximal variation sampling that took account of patient and caregiver baseline HRQoL scores, caregiver demographics (age, gender and ethnicity), and geographical location. Home interviews were conducted by two experienced qualitative researchers (JW, Lucy Moore). Caregivers were encouraged to describe their views and experiences of the REACH-HF intervention. Interviewers were guided by answers from the interviewees and used further probing questions such as 'tell me more about ...?' Other techniques to enhance the interview included reflecting on what was said and using non-verbal communication to show that the researcher was actively listing. Interviewers summarized the content of the interview at the end of the discussion and invited the participant to add anything else they wanted to share. The interview topic guide ([Supplementary table 1](https://journals.sagepub.com/doi/suppl/10.1177/1474515119850011)) was reviewed throughout the study so that the questions were informed by relevant emerging topics, e.g. the impact of roles outside the home and the difficulties encountered by caregivers who did not live with the cared for person. Interviews were audio recorded and researchers wrote field notes at the end of each interview detailing observations of the home and social context; reflections on researcher performance and potential influence on the interview; how the participant responded to the questions; and initial thoughts about the main points arising from the interview.

Data analysis {#section10-1474515119850011}
-------------

The sample size of the study was based on a minimal clinically important difference (5 points) in the HF patient primary outcome measure (Minnesota Living with Heart Failure Questionnaire) and assumed attrition rate of 10%. At type I error of 0.05 and power of 90% this required a total of 108 patients per group were required. The was no formal sample size calculation for the number of caregivers participating in this study.

### Quantitative analysis {#section11-1474515119850011}

All statistical analyses were conducted to a predefined analysis plan agreed in advance with the trial management group, Trial Steering committee and Data Management committee. Caregiver outcomes are reported descriptively by group at all assessment points (baseline, and 4 and 12 months follow-up). REACH-HF and control group caregiver outcomes are compared at 12-months using linear regression methods, adjusting for baseline score. All between-group outcome comparisons are presented intention-to-treat basis (i.e. according to group allocation at baseline) in caregivers with complete outcome data at 12 months and are reported as mean differences with a 95% confidence interval (CI). No imputation for missing data was undertaken. Analyses were undertaken by the trial statistician (FCW) who was blinded to group allocation and according to a predefined analysis plan using Stata version 14.1. No interim analyses were performed.

### Qualitative analysis {#section12-1474515119850011}

A thematic analysis was conducted by two experienced qualitative researchers (JW and JF).^[@bibr21-1474515119850011]^ Interview audio tapes were transcribed verbatim. The data set included: facilitator contact sheets, baseline questionnaire data, field notes, and interview transcripts. Data was managed by NVIVO 11 Pro. Sections of data related to the aims were assigned a code that summarized the content either descriptively or interpretively. Codes with common features were grouped together in emerging themes, before finally being assigned to overarching, interpretive themes. Constant comparative techniques were used to compare individual 4- and 12-month interviews and across all caregiver participants' interviews.^[@bibr22-1474515119850011]^ An additional analytical memo note was used to note and test early hypotheses and explore emergent hypotheses from the data.

Results {#section13-1474515119850011}
=======

Study sample {#section14-1474515119850011}
------------

Between January 2015 and February 2016, 216 HFrEF patients were randomly allocated to the REACH-HF group (*n* = 107) and control group (n = 109). A total of 97 patients declared a caregiver - 53 caregivers in the REACH-HF and 44 in the control group. At 12 months, outcomes data was available from 45 (85%) caregivers in the REACH-HF group and 37 controls (84%) (see [Figure 1](#fig1-1474515119850011){ref-type="fig"}).

![CONSORT flow diagram.](10.1177_1474515119850011-fig1){#fig1-1474515119850011}

Baseline characteristics {#section15-1474515119850011}
------------------------

Caregivers were typically the partner or direct relative, were of a younger mean age than participating patients and predominantly female. There was evidence of imbalance in caregiver baseline demographic characteristics and outcome scores between groups; controls were older and had higher levels of depression and anxiety and lower generic HRQoL ([Tables 1](#table1-1474515119850011){ref-type="table"} and [2](#table2-1474515119850011){ref-type="table"}).

###### 

Characteristics of caregivers and HF patients they care for.

![](10.1177_1474515119850011-table1)

                                                                         **REACH-HF group**   **Control group**
  ---------------------------------------------------------------------- -------------------- -------------------
  **Caregivers**                                                                              
  Gender: female, *n* (%)                                                43 (81)              33 (75)
  Age: years, mean (SD)                                                  62.8 (14.7)          68.2 (11.3)
  Relationship to patient: *n* (%)                                                            
   Spouse/partner                                                        44 (83)              36 (82)
   Direct family                                                         5 (9)                6 (14)
   Other relative                                                        1 (2)                1 (2)
   Friend                                                                3 (6)                1 (2)
  Employment status: *n* (%)                                                                  
   Employment/self-employment                                            15 (28)              6 (14)
   Retired                                                               35 (66)              33 (75)
   Housework                                                             2 (4)                0 (0)
   Unemployed                                                            1 (2)                3 (7)
   Other                                                                 0 (0)                2 (5)
  Location: *n* (%)                                                                           
   Birmingham                                                            6 (11)               8 (18)
   Cornwall                                                              19 (36)              14 (32)
   South Wales                                                           13 (25)              10 (23)
   York                                                                  15 (28)              12 (27)
  **Patients** ^[a](#table-fn1-1474515119850011){ref-type="table-fn"}^                        
   Gender: female, *n* (%)                                               13 (25)              9 (20)
   Age: years, mean (SD)                                                 69.4 (10.9)          71.3 (10.3)
  Employment status: *n* (%)                                                                  
   Employment/self-employment                                            7 (13)               3 (7)
  Retired                                                                43 (81)              36 (82)
  Housework                                                              0 (0)                1 (2)
  Unemployed                                                             2 (4)                1 (2)
  Other                                                                  1 (2)                3 (7)
  Living alone, *n* (%)                                                  6 (11)               3 (7)
  NYHA: *n* (%)                                                                               
   Class I                                                               11 (21)              8 (18)
   Class II                                                              29 (55)              25 (57)
   Class III                                                             13 (25)              11 (25)
   Class IV                                                              0 (0)                0 (0)
  Ejection fraction: mean (SD), *n*                                      31.0 (8.8), 40       31.3 (8.6), 34

Demographic and clinical characteristics of HF patients with caregivers.

###### 

Caregiver reported outcomes at baseline and follow-up. Data are means (SD, *n*) unless otherwise indicated.

![](10.1177_1474515119850011-table2)

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Outcome** (possible range of scores: best to worst)                                             **Baseline**        **4 months**        **6 months**        **12 months**                                                                                       
  ------------------------------------------------------------------------------------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- --------------------------------
  HADS\                                                                                             6.3 (4.6), 53       7.6 (4.0), 44       5.5 (4.9), 46       6.8 (4.0), 36       5.1 (4.8), 43       6.2 (3.8), 38       5.3 (5.2), 43       6.1 (3.8), 33       0.0 (−1.4 to 1.4), 0.979
  anxiety (0--21)                                                                                                                                                                                                                                                   

  HADS\                                                                                             3.3 (3.2), 53       4.0 (3.0), 44       3.0 (3.5), 46       2.5 (2.6), 36       2.8 (3.3), 43       3.8 (3.1), 38       3.1 (3.4), 43       2.8 (2.8), 33       0.7 (−0.2 to 1.6), 0.130
  depression (0--21)                                                                                                                                                                                                                                                

  Fam-Qol\                                                                                          59.7 (9.9), 53      59.9 (8.9), 44      62.4 (10.9), 45     65.1 (10.7), 37     61.3 (10.2), 44     61.2 (8.8), 38      60.5 (10.4), 43     61.5 (10.6), 33     0.1 (−3.8 to 4.0), 0.971
  overall (80 to 16)                                                                                                                                                                                                                                                

  Fam-Qol\                                                                                          16.4 (3.0), 53      16.8 (2.6), 44      16.9 (3), 45        17.7 (2.3), 37      16.5 (2.8), 44      16.7 (2.4), 38      16.5 (3.2), 43      16.2 (2.9), 33      0.9 (−0.3 to 2.0), 0.139
  physical (20 to 4)                                                                                                                                                                                                                                                

  Fam-Qol psychological (20 to 4)                                                                   14.2 (4.5), 53      13.7 (3.8), 44      15.3 (4.4), 45      15.7 (4.2), 37      14.9 (4.2), 44      14.4 (3.1), 38      14.9 (4.3), 43      15 (4.0), 33        −0.1 (−1.5 to 1.4), 0.939

  Fam-Qol\                                                                                          16.6 (3.1), 52      15.5 (3.8), 44      16.9 (3.3), 45      17.2 (3.0), 37      16.3 (3.1), 44      15.9 (3.0), 38      16.5 (3.2), 43      16.2 (3.6), 33      −0.2 (−1.5 to 1.2), 0.810
  social life (20 to 4)                                                                                                                                                                                                                                             

  CBQ-HF\                                                                                           3.8 (4.4), 53       3.6 (4.4), 44       2.8 (3.9), 46       2.4 (3.2), 37       2.7 (3.2), 44       3.4 (3.7), 38       2.7 (3.6), 43       3.6 (4.5), 33       −1.0 (−2.5 to 0.5), 0.191
  physical (0--20)                                                                                                                                                                                                                                                  

  CBQ-HF emotional (0--60)                                                                          15.6 (12.4), 53     16.0 (10.9), 44     14.3 (10.7), 46     12.5 (11.2), 37     14.0 (9.9), 44      14.7 (10.6), 38     13.7 (10.6), 43     13.6 (10.9), 33     −0.7 (−4.6 to 3.1), 0.700

  CBQ-HF\                                                                                           1.4 (1.9), 53       0.9 (1.5), 44       0.8 (1.2), 46       0.6 (1.3), 37       1.1 (1.5), 43       1.1 (1.9), 37       0.9 (1.3), 43       1.2 (1.6), 33       −0.6 (−1.1 to 0.0), 0.058
  social life (0--8)                                                                                                                                                                                                                                                

  CBQ-HF\                                                                                           3.4 (4.4), 53       3.0 (3.1), 44       2.3 (2.9), 46       3.0 (3.5), 37       2.4 (2.9), 44       3.6 (4.1), 37       2.3 (3.2), 43       2.8 (3.4), 33       −0.7 (−1.9 to 0.5), 0.244
  lifestyle (0--16)                                                                                                                                                                                                                                                 

  EQ-5D-5L (0.00--1.00)                                                                             0.828 (0.186), 53   0.797 (0.147), 44   0.847 (0.166), 46   0.798 (0.202), 36   0.828 (0.147), 44   0.783 (0.158), 36   0.825 (0.150), 42   0.776 (0.188), 33   0.021 (−0.057 to 0.098), 0.599

  CC-SCHFI maintenance (0--100)                                                                     36.5 (21.6), 53     42.7 (20.3), 44     42.9 (25.5), 46     42.0 (20.6), 37     43.8 (22.7), 44     41.0 (20.6), 37     42.2 (24.8), 43     39.8 (20.5), 33     7.3 (−1.6 to 16.2), 0.108

  CC-SCHFI management^[b](#table-fn3-1474515119850011){ref-type="table-fn"}^ maintenance (0--100)   39.0 (21.9), 24     45.2 (17.9), 21     52.7 (19.7), 11     49.7 (14.8), 15     44.7 (22.4), 17     42.5 (22.5), 16     50.5 (23.2), 20     52.5 (24.9), 16     8.9 (−14.1 to 31.9), 0.419

  CC-SCHFI\                                                                                         55.3 (24.0), 53     51.8 (24.8), 44     57.9 (23.0), 45     56.8 (25.4), 37     58.8 (22.5), 41     57.5 (21.7), 38     62.8 (21.9), 43     50.8 (24.9), 33     9.3 (1.8--16.8), 0.016
  confidence maintenance (0--100)                                                                                                                                                                                                                                   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mean differences adjust for baseline values.

Participants excluded if at least one missing value.

Outcomes {#section16-1474515119850011}
--------

There was evidence of improvements from baseline at 4, 6 and 12 months follow-up in a number of caregiver outcomes in the REACH-HF group, including HADS-anxiety, CBQ-HF physical, social life and lifestyle and all SCHFI dimension scores. Compared to controls, the only significant difference was in mean CC-SCHFI confidence score at 12-months (57.5 vs 62.8, adjusted mean difference: 9.3, 95% CI: 1.8--16.8, *p* = 0.016. [Table 2](#table2-1474515119850011){ref-type="table"} shows the outcome means and standard deviations in both groups.

Interviews {#section17-1474515119850011}
----------

One caregiver declined to be audio recorded and was excluded from the analysis. The 19 caregivers who agreed to be interviewed had similar demographic characteristics to the overall study cohort of caregivers ([Supplementary table 2](https://journals.sagepub.com/doi/suppl/10.1177/1474515119850011)). All 19 caregivers were interviewed at four months and 16 were interviewed at 12 months (one withdrew as her husband was unwell and two declined to take part). The majority of interviews were conducted in the patient's home (usually with the patient present) and the average duration of interviews was 51 min (range 15--103) and 43 min (range 13--100) at 4 and 12 months respectively.

Two overarching themes emerged from interviews: (1) engagement with the REACH-HF intervention and (2) impact on caregiver role. These themes and related subthemes are described below.

### Theme 1: engagement with the REACH-HF intervention {#section18-1474515119850011}

#### Expectations {#section19-1474515119850011}

and hope

Most caregivers spoke of hope that the cared for person would make changes in lifestyle or have professional guidance on how best to manage HF and what to do in an emergency.

"*My goal is that he keeps it \[heart failure\] off, and keeps himself healthy, because we have discussed the only alternative. That if he's unable to look after my mum, the most horrendous thing that could happen to them both is that mum has to be put in a home or something like that, and he can't bear that.*(Male caregiver -- son, aged 49 years)"

Few caregivers had expectations for their own health and wellbeing but most expressed feeling valued as they were included in the intervention.

#### Engagement {#section20-1474515119850011}

with the intervention

While many caregivers did engage with the intervention, there was evidence that some caregivers actively chose to not engage with the facilitator and obstructed facilitator efforts to engage. Proactive engagement was enhanced when the patient made perceived improvements in HRQoL, especially if there was an improvement in social activities. These engaged caregivers were also more likely to have a wider close social support network, and there are examples where the 'family and friends resource' as shared with this social network. Conversely, fear of hospitalization of the cared for person could also act a factor motivating active engagement.

"*The manual was on the table and shows signs of wear and has post it notes on it. She has from time to time looked at it for referral and comfort. She could not recall a specific example but the look of the manual shows someone is using it. The Family and Friends resource also had book marked sections -- symptoms and what to do in an emergency and when to call for help. There was a sense of being prepared for an emergency which I reflected back to her and she agreed*.(Field notes: Female caregiver -- wife aged 74)"

#### Factors influencing non-engagement or limited/passive engagement {#section21-1474515119850011}

Those caregivers who had a good relationship with an existing nurse or health professional were less likely to see the need for the intervention or to understand that the intervention could be used to address their own health and wellbeing. Employed caregivers had no or little facilitator contact. One facilitator attempted on multiple occasions to contact a caregiver but the caregiver did not return the calls, and this obstructed engagement. Non-engaged caregivers often felt they already had the knowledge and skills they required.

"*When \[wife\] went for consultations at the hospital or with the \[surgeon\], with the doctors and everything, generally I was there. So I knew what they \[facilitator\] had to say and what their opinions generally were. And we had information anyway about the heart conditions because we get this, (British) Heart Foundation magazine, which is really quite interesting. I'm not really a novice in the game if you like and haven't been really from the start.*(Male caregiver -- husband, aged 84)"

#### Resource use {#section22-1474515119850011}

All sections of the REACH-HF family and friends' resource were used by at least one caregiver and the most used sections related to managing signs and symptoms, what to do in an emergency and when to call for help.

"*I think there's -- in there there's a website for um carers ... and you think 'Well, hang on a minute, yeah, there are other people out there and they all understand exactly how you feel'. Isolated, I suppose, that's the word, I don't feel so isolated anymore.*"

#### Impact of research processes {#section23-1474515119850011}

An unexpected finding was the significance of the caregiver questionnaires used to collect baseline quantitative outcome data in the trial research nurse appointments. The HADS and HRQoL outcome questionnaires acted as a 'stop and think' moment to reflect for the first time on the impact of being caregivers. Some reported that as a result they were more honest when completing the questionnaire at the follow-up data collection points.

"*It was bang on the money but there was no reference to that throughout the... \[Intervention\]. Throughout the study. If that was, if that could be a constructive criticism. ....................................But that questionnaire was perfect.*(Male caregiver -- husband aged 45)"

### Theme 2: impact on caregiver role {#section24-1474515119850011}

When asked about their role, there were two distinct groupings: (1) caregivers who were proactive or 'enabling' in supporting self-management activities and (2) caregivers who believed the locus of control for self-management should be with the cared-for person. As a result of the REACH-HF intervention, some caregivers adopted a more supportive role using the advice in the 'Family and Friends Resource' to discuss how the person was feeling and then agree a mutual management plan.

#### Informed vigilance {#section25-1474515119850011}

Most caregivers also spoke of the importance of knowing the individual and looked for facial clues such as pallor and dullness of eyes. Vigilance was often reported as a constant covert activity that could be enhanced by REACH-HF.

"*Because, with the heart failure manual it tells you what to look out for. When you first have got heart failure you don't know what to look out for. It's that you've got no signs, you've got no reference, but with the manual there is that little bit of reference there that says, this is what you need to do. You need to seek medical attention ASAP. Basically that's what it's telling you.*(Female caregiver -- wife, aged 41)"

#### Relationship with cared-for person {#section26-1474515119850011}

The intervention was more effective when the couple appeared to have an open honest relationship about the impact of HF, its management and outlook for the future. Two of the adult children reported role reversal making the encouragement of self-management activities difficult.

#### Supporting physical activity {#section27-1474515119850011}

The REACH-HF walking programme was seen as an opportunity to get out socially, as well as to get some exercise for those caregivers who walked with the cared-for person. At 12 months, the minority who had experienced a significant health setback for the cared-for person, spoke confidently of restarting the exercise programme.

"*It's given me a pathway to take her down. And, as far as I'm concerned, your programme, it gave me something to do at the time it was needed, but it has also given me something I can do in the future. So your programme is brilliant because it..., has given us a way forward and an improving way forward for when it happened. And now we've got the resources that, already on hand that we know, that we can use again, time and time as required.*(Female caregiver -- friend, aged 68)"

#### Supporting emotional and stress management {#section28-1474515119850011}

Those caregivers who had an open relationship or reported getting closer were also more likely to support each other emotionally.

#### Supporting medication management {#section29-1474515119850011}

Many caregivers read the medication sections of the manual and there was evidence of learning about side effects, dietary interactions, preventing flu and over the counter remedies.

"*I didn't actually know that he shouldn't really be having spinach and green leafy vegetables, because they're blood thinners and don't go with the warfarin. I don't think I'd ever been told that before, so that was something that I didn't know. And things like when to... When you really should be contacting the heart nurse or the surgery and when you can try to do things yourself, like taking an extra Furosemide, if needed.*(Female caregiver --wife, aged 65)"

#### Impact on caregiver health {#section30-1474515119850011}

There was a strong link between the health of the caregiver and the health of the HF patient. However, caregivers made few changes to management of their own health.

"*I've always, well I joined the gym when I retired anyway, you know, but you go into these phases where you're going or not. And I stopped going because \[husband\] wasn't all that well and my daughters had said to me, 'Mum, you've got to start doing things for yourself.' So, sort of, you know, encouraged by them and then I thought, 'Right, this \[resource\], It's almost like gives you permission, like it's okay to do this.'*(Female caregiver -- wife, aged 64)"

Discussion {#section31-1474515119850011}
==========

We report the impact on caregivers of REACH-HF -- a novel, home-based, self-management intervention aimed at both HF patients and their caregivers. Compared to control, there was no significant difference in caregiver outcome with exception of CC-SCHFI confidence score. However, our qualitative research showed that most caregivers who received the REACH-HF intervention, made positive changes to how they supported the HF patient they were caring for, and perceived that they had increased their confidence in the caregiver role.

Our findings provide important evidence of the impact of a rehabilitation and self-management intervention for HF patients on caregiver outcomes. We know of only one previous randomized trial that was undertaken in a single centre UK setting. Witham et al assessed a 24-week exercise-based CR intervention in functionally impaired elderly (⩾70 years) HF patients.^[@bibr23-1474515119850011]^ Compared to no exercise control, the authors reported no significant difference at 8 or 24 weeks in either patient or caregiver outcomes. Caregiver outcomes collected were similar to the present study, i.e. mental wellbeing (HADS anxiety and depression) and burden/strain (Zarit Burden Interview). Whilst the Witham trial encouraged caregivers to involve themselves in the exercise training sessions of patients, there was no mention of involvement of caregivers in the intervention development or delivery (only 10/71 caregivers in the trial accepted the invitation to participate in the exercise programme). In contrast, the REACH-HF intervention was co-designed with several stakeholders, including caregivers, and included a formal element of the intervention ('family and friends resource') specifically aimed at caregivers.

Strengths of this study included its multicentre design, collection of a range of questionnaire-based outcomes intended to assess mental wellbeing, burden and HRQoL of caregivers, and the mixed methods design that included in depth interviews with caregivers. However, this study has some important limitations that may explain the lack of quantitative differences between the intervention and control groups. First, baseline mean HADS depression, Fam-Qol and CBQ-HF scores indicated consistently good levels of caregiver functioning and, therefore, little room for further improvement. Second, caregivers were not themselves randomized to intervention and control groups, increasing the risk of selection bias and cofounding in the comparison of REACH-HF and control groups. Third, given the primary aim of the trial was to assess the impact of REACH-HF on HF patients, the study sample size was powered on the between-group difference in patient rather than for caregivers. For example, if we had powered the trial based on detection of a minimum clinically important difference for the HADS score of 1.4 would have required a sample size of 227 caregivers per group (at 90% power and 5% alpha).^[@bibr24-1474515119850011]^ As this minimum clinically important difference lies well inside the 95% CI for the between-group difference in HADS anxiety and HADS depression seen in the current study at 12 months, we cannot rule out a clinically important effect of REACH-HF intervention upon caregivers. Finally, our trial process evaluation found that healthcare staff facilitating the REACH-HF intervention appeared to be less effective in involving of caregivers than patients.

There is a growing interest in including caregivers in intervention delivery.^[@bibr2-1474515119850011][@bibr3-1474515119850011]--[@bibr4-1474515119850011]^ One of the key implications of this study is the need to better engage caregivers in rehabilitation and self-management interventions for HF patients. We recognize that actively working with caregivers may have been a new experience for many of the healthcare facilitators who participated in this trial and we are currently making adaptations to reflect this in our REACH-HF facilitator training. A structured caregiver assessment tool may assist facilitators to plan and deliver this aspect of the intervention.^[@bibr12-1474515119850011]^ Further high quality evidence is required to confirm the benefits of actively involving caregivers in the development and delivery of rehabilitation and self-management interventions for HF and other chronic diseases.
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Implications for practiceThere are few evidence-based interventions to support caregivers for people with chronic disease.Provision of the Rehabilitation EnAblement in Chronic Heart Failure (REACH-HF) intervention for caregivers of patients with heart failure may improve their confidence to support self-management and was perceived to be helpful in maintaining their role as caregivers.Refinements of the REACH-HF intervention have been made ahead of its roll out into the UK National Health Service, including strategies to better target caregivers.
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